NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT)’s sale to Indivior PLC. Per the agreement, Indivior would acquire Opiant for $20.00 per share in cash, plus up to $8.00 per share in contingent value rights that may become payable in the event that certain net revenue milestones are achieved during the relevant seven-year period by OPNT003 after its approval and launch. If you are an Opiant shareholder, click here to learn more about your rights and options.
Imago BioSciences, Inc. (NASDAQ: IMGO)’s sale to Merck for $36.00 per share in cash. If you are an Imago shareholder, click here to learn more about your rights and options.
Salisbury Bancorp, Inc. (NASDAQ: SAL)’s sale to NBT Bancorp Inc. for 0.7450 shares of NBT common stock for each share of Salisbury. If you are a Salisbury shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
